ROSC and Post-Cardiac Arrest Care: What You Need to Understand
A cardiologist explains what happens after cardiac arrest is reversed, how post-cardiac arrest syndrome causes multi-organ injury, and what ROSC care involves.
What It Is
Return of Spontaneous Circulation
Return of spontaneous circulation (ROSC) means the heart has resumed effective mechanical activity, producing a palpable pulse. It is the first milestone in cardiac arrest survival. It is not recovery. It is not neurological survival. It is the opening of a window.
In out-of-hospital cardiac arrest, approximately 25 to 40 percent of patients achieve ROSC at some point before or on arrival to the hospital 5 / Solid . Of those, fewer than half survive to hospital discharge. Of those who survive to discharge, a significant proportion have permanent neurological impairment.
The gap between ROSC and meaningful survival is the clinical problem that post-arrest care addresses.
Post-Cardiac Arrest Syndrome
Post-cardiac arrest syndrome (PCAS) is the constellation of pathophysiological derangements that follow resuscitation. It was formally characterized by Neumar and colleagues in 2008 5 / Solid and incorporated into resuscitation guidelines. It has four components:
Post-cardiac arrest brain injury: The dominant cause of death and disability in survivors. Ischemia-reperfusion injures neurons during the arrest; reperfusion injury continues after ROSC through oxidative stress, calcium influx, excitotoxicity, and programmed cell death cascades. The injury evolves over 24 to 72 hours, which is why prognostication in the first 24 hours is unreliable and premature prognostication is one of the most dangerous errors in post-arrest care.
Post-cardiac arrest myocardial dysfunction: The heart that was just resuscitated is not normal. Stunning (reversible myocardial dysfunction from ischemia without permanent damage) occurs in most ROSC patients. Ejection fraction may temporarily fall to 20 to 30 percent even in patients with structurally normal hearts. This dysfunction typically peaks at 24 to 48 hours and recovers over 72 hours in surviving patients 5 / Solid 02128-4).
Systemic ischemia-reperfusion response: The whole-body ischemia during cardiac arrest activates inflammatory cascades similar to sepsis physiology. Cytokine release, endothelial activation, coagulopathy, and adrenal insufficiency are all documented in post-arrest patients. Hemodynamic management reflects both cardiogenic shock (from myocardial dysfunction) and distributive shock (from systemic inflammatory response).
Persistent precipitating pathology: The cause of the arrest is still present. If a coronary plaque ruptured, it may still be occluded or partially treated. If electrolyte abnormalities triggered VFib, they require correction. If the arrest resulted from a pulmonary embolism, the clot is still there.
The Mechanism
The Ischemia-Reperfusion Injury Cascade
During cardiac arrest, every organ receives no oxygen. Neurons are the most sensitive: irreversible injury begins at four to six minutes. But the injury does not end when blood flow is restored. Reperfusion paradoxically causes additional damage through several mechanisms:
Reactive oxygen species (ROS): The sudden reintroduction of oxygen to cells that have been generating ATP through anaerobic glycolysis produces a burst of superoxide, hydrogen peroxide, and hydroxyl radicals. These oxidize cell membranes, proteins, and DNA 5 / Solid .
Calcium overload: Ischemia disrupts calcium regulation. Reperfusion floods cells with calcium, activating proteases, lipases, and apoptotic pathways. Neuronal calcium overload is a primary driver of post-arrest cognitive injury.
Mitochondrial permeability transition: The mitochondrial permeability transition pore (mPTP) opens during reperfusion, causing cytochrome c release and triggering intrinsic apoptosis. Cooling (the rationale for targeted temperature management) reduces mPTP opening.
Excitotoxicity: Ischemic neurons release massive amounts of glutamate. Glutamate binds NMDA receptors, causing uncontrolled calcium influx and neuronal death. This is the rationale for several neuroprotective drug strategies that have failed in clinical trials.
Why the Brain Does Not Recover Equally
The brain’s regions are not equally vulnerable to ischemia. The hippocampus (memory consolidation), the Purkinje cells of the cerebellum (coordination), and the cortical neurons of layers 3, 5, and 6 are most vulnerable. Deep cortical structures, the brainstem, and the thalamus have greater ischemic tolerance.
This selective vulnerability explains the spectrum of post-arrest neurological injury: some patients wake with essentially no deficit. Others have preserved brainstem function (they breathe, maintain blood pressure, open eyes to pain) but have destroyed cortical function, the vegetative state. The spectrum is continuous, and the EEG, MRI, and clinical examination over 72 to 96 hours are the tools used to distinguish it.
Post-Arrest Myocardial Stunning
The stunned myocardium after ROSC is driven by similar mechanisms: calcium overload, ROS, and energy depletion. The good news is that myocardial stunning is fully reversible in most patients who survive the critical period. The ejection fraction that is 20 percent on hospital day one may be 45 percent on day seven. This is why aggressive hemodynamic support in the first 48 to 72 hours (vasopressors, inotropes, possibly mechanical circulatory support) is warranted even in patients with no prior cardiac history, without assuming permanent cardiomyopathy.
How We Diagnose / How It Is Used
The Post-Arrest Care Bundle
Post-arrest care is managed through a bundle of interventions, each targeting a component of the post-cardiac arrest syndrome. No single intervention defines post-arrest care; the aggregate effect of the bundle, when delivered consistently, explains the outcomes differences between high-performing centers and average ones.
Hemodynamic targets: The standard post-arrest hemodynamic targets are mean arterial pressure (MAP) above 65 to 70 mmHg, oxygen saturation 94 to 96 percent (avoiding hyperoxia, which worsens reperfusion injury 4 / Promising ), and avoidance of hypercapnia and hypocapnia (targeting PaCO2 35 to 45 mmHg).
Temperature management: Fever avoidance or targeted normothermia is now the standard following the TTM2 trial (Dankiewicz et al., NEJM 2021, 10.1056/NEJMoa2100591). This is covered in depth in the TTM article (SDE-F-CODE-004).
Urgent coronary angiography: For post-arrest patients with ST elevation on ECG, immediate coronary angiography and PCI is indicated, as in standard STEMI care 5 / Solid . For patients without ST elevation, the COACT trial changed practice.
Seizure management: Post-arrest seizures occur in approximately 10 to 30 percent of comatose survivors. They worsen neurological injury by increasing brain metabolic demand. Continuous EEG monitoring in the first 24 to 48 hours identifies seizures that are not clinically apparent (non-convulsive status epilepticus) and guides treatment with levetiracetam, valproate, or midazolam infusion 5 / Solid .
Glycemic management: Hypoglycemia worsens neurological outcomes post-arrest. Moderate glycemic control targeting blood glucose 144 to 180 mg/dL is recommended 5 / Solid .
The COACT Trial: No Benefit to Immediate Angiography Without ST Elevation
The COACT trial (Lemkes et al., NEJM 2019, 10.1056/NEJMoa1816889) randomized 552 comatose post-OHCA patients without ST elevation to immediate coronary angiography vs delayed angiography (after neurological recovery or 48+ hours). Survival at 90 days was identical: 64.5% immediate vs 67.2% delayed (p=0.54). Troponin release, kidney injury, and length of stay were not significantly different.
The clinical implication: in comatose post-arrest patients without ST elevation, stabilizing the patient and addressing temperature management first, with angiography when the patient is stabilized or when neurological recovery allows, is non-inferior to rushing to the cath lab immediately. This does not mean the underlying CAD is not important; it means the timing of the intervention does not change survival in this population.
This trial changed the default practice in many centers. The previous reflex to take every post-arrest patient to the cath lab immediately, regardless of ECG, is no longer supported by evidence.
Neurological Prognostication
Neurological prognostication after cardiac arrest is one of the most consequential clinical decisions in medicine and one of the most error-prone. The challenge: in the first 24 to 72 hours after ROSC, clinical examination, EEG, and laboratory markers all have significant false-positive rates for predicting a poor outcome. Premature prognostication, the clinical judgment that a patient will not have meaningful neurological recovery before adequate time has elapsed, leads to withdrawal of care and creates a self-fulfilling prophecy.
The European Resuscitation Council and AHA recommend a structured multimodal prognostication algorithm, beginning no earlier than 72 hours after ROSC (or 72 hours after normothermia achievement, as sedatives and hypothermia affect examination reliability) 5 / Solid :
| Tool | When to Use | Findings Predicting Poor Outcome |
|---|---|---|
| Clinical exam | > 72 h post-arrest | Absent pupillary light reflex bilaterally; absent corneal reflex |
| EEG | 24-48 h | Burst suppression without reactivity; absence of EEG reactivity |
| Somatosensory evoked potentials (SSEPs) | 24-72 h | Bilaterally absent cortical N20 response |
| CT/MRI brain | 24-72 h | Diffuse anoxic injury pattern; marked loss of gray-white differentiation |
| Neuron-specific enolase (NSE) | 48-72 h | Values > 60-90 mcg/L at 48-72 h (threshold varies by lab and temperature history) |
No single finding is sufficient for a poor prognosis designation. The multimodal approach combines at least two concordant findings from the above. Any discordance mandates caution.
CPC Neurological Outcome Scale
The Cerebral Performance Category (CPC) scale grades neurological recovery after cardiac arrest:
- CPC 1: Good neurological recovery; normal function or mild deficit
- CPC 2: Moderate disability; independent in activities of daily living
- CPC 3: Severe disability; dependent
- CPC 4: Vegetative state
- CPC 5: Death
Most cardiac arrest survival trials use “favorable neurological outcome” as CPC 1 or 2, combining good and moderate recovery. This is an important distinction when interpreting trial results: a drug that improves survival but increases CPC 3-4 survivors (epinephrine, per PARAMEDIC2 data) is not straightforwardly beneficial from a patient-centered standpoint.
The Evidence
Key Trials in Post-Arrest Care
| Study | N | Key Finding | Honesty Scale |
|---|---|---|---|
| COACT (Lemkes 2019, NEJM) | 552 | Immediate vs delayed angiography: no survival difference without ST elevation | Solid |
| TTM2 (Dankiewicz 2021, NEJM) | 1,900 | Normothermia non-inferior to 33C cooling | Solid |
| HYPERION (Lascarrou 2019, NEJM) | 584 | 33C cooling: higher favorable neuro outcome vs 37C in non-shockable arrests (29% vs 17%) | Promising |
| CORONARY (Annane 2019, NEJM) | 512 | Hydrocortisone + fludrocortisone: improved survival in post-arrest shock | Promising |
| Stub (Circulation 2012) | 411 | Titrated oxygen vs high-flow oxygen post-ROSC: lower troponin with titrated | Promising |
| Nolan (Resuscitation 2021) | Guidelines review | Multimodal prognostication at > 72h: lowest self-fulfilling prophecy risk | Solid |
The Hyperoxia Problem
Supplemental oxygen after ROSC was historically delivered at 100 percent FiO2. The rationale seemed obvious: the patient had just been hypoxic. More oxygen would correct the deficit.
The problem: post-arrest reperfusion injury is driven in part by reactive oxygen species. Excess oxygen, particularly at the mitochondrial level, amplifies this damage. Animal studies and retrospective clinical analyses consistently show worse neurological outcomes with hyperoxia post-ROSC 4 / Promising . The current guideline target is SpO2 94 to 96 percent, not 100 percent. This is a small change in practice that has strong physiological rationale.
The Failed Neuroprotective Drug Era
No pharmacological neuroprotective agent has demonstrated benefit in post-arrest trials. Cyclosporine (to block mPTP), magnesium, nimodipine, thiopental, and several others have been tested in RCTs and have failed 5 / Solid . The TTM strategy (cooling to 33C) was the most physiologically coherent and clinically implemented approach to neuroprotection, and it too has been supplanted by normothermia in most patients (with the exception of the HYPERION non-shockable arrest subgroup).
The negative neuroprotective trial results reflect two realities: the complexity of post-arrest brain injury as a multi-pathway process that is difficult to interrupt at a single pharmacological target, and the challenge of early treatment windows (most neuroprotective drugs need to reach target tissues before or during reperfusion, not hours later in an ICU).
Prognosis at 90 Days
For patients who achieve ROSC after OHCA and are admitted to the ICU, the overall 90-day survival depends heavily on presenting rhythm and witness status. In the COACT trial, which enrolled comatose post-arrest patients, 90-day survival was approximately 65 percent. In populations that include non-shockable presenting rhythms, outcomes are worse: 90-day survival approaches 20 to 30 percent.
Among survivors, approximately 60 to 70 percent achieve CPC 1-2 (good or moderate neurological outcome) 5 / Solid . The remainder have CPC 3-5. This is an important context for discussions with families: the majority of patients who survive cardiac arrest with good management do recover meaningful neurological function.
The Patient Experience
The Forty-Eight Hours That the Family Waits
When a patient achieves ROSC and is admitted to the ICU, the family begins a waiting period with no clear timeline. The patient is unconscious, intubated, surrounded by equipment, and unresponsive. The nursing staff is titrating vasopressors, managing the ventilator, and monitoring continuous EEG. The family asks: “Will he wake up?”
The honest clinical answer in the first 24 to 72 hours is: we do not know yet. Prognostication before 72 hours is unreliable. That uncertainty is distressing, but the alternative, premature certainty about a poor outcome, is medically and ethically worse.
Studies document that families of post-arrest patients experience significant psychological distress regardless of outcome 5 / Solid . Proactive communication, structured family meetings with clear timelines (“We will have a much better sense of his neurological picture at 72 hours from when his temperature normalized”), and consistent messaging from the care team all reduce distress without requiring false optimism.
Post-Arrest Cognitive Syndrome in Survivors
Patients who achieve meaningful neurological recovery after cardiac arrest do not emerge uniformly intact. Post-arrest cognitive syndrome describes a constellation of deficits that persist after ICU discharge:
- Executive function impairment (planning, initiation, inhibition)
- Memory consolidation difficulties
- Attention deficits
- Fatigue and reduced processing speed
- Anxiety and PTSD symptoms
These deficits affect approximately 50 to 70 percent of survivors to some degree at hospital discharge 5 / Solid . Many improve over the first six months. Some persist. Neuropsychological testing, cardiac rehabilitation programs that include cognitive rehabilitation components, and structured follow-up at three and six months are the recommended post-discharge approach for these patients.
The Survivor Who Feels Fine and Is Not
The subset of cardiac arrest survivors with CPC 1 at discharge represent a clinical success. They are often sent home with an ICD implanted, medications optimized, and a follow-up appointment scheduled. The risk is that they feel well enough to resume their prior activity level and to dismiss the cognitive sequelae they are experiencing as tiredness.
The AVOID-HF and post-arrest survivor registry data suggest that return to work and full activity by six months is achievable in the majority of CPC 1 survivors, but this requires proactive rehabilitation, not passive observation 4 / Promising .
Decisions and Trade-Offs
When to Stop Resuscitation
The decision to terminate resuscitation is made in the field (for EMS) or in the emergency department (for in-hospital arrests) when signs of life have not been achieved and resuscitation criteria (prolonged downtime, non-shockable rhythm, no reversible cause identified, no ROSC) are met. Standard EMS protocols vary by state.
The harder question is ICU withdrawal of care in a patient who has achieved ROSC but is showing progressively worse prognostic signs. The multimodal prognostication algorithm is designed to ensure that this decision is made with appropriate evidence and not prematurely. Centers with structured, protocol-driven post-arrest programs document significantly lower rates of “premature prognostication withdrawal” compared to centers without such protocols 4 / Promising .
Mechanical Circulatory Support in Post-Arrest Cardiogenic Shock
For post-arrest patients with profound refractory cardiogenic shock (MAP persistently below 65 despite maximal vasopressor and inotrope therapy), mechanical circulatory support (MCS) is increasingly used as a bridge. Options include:
- Intra-aortic balloon pump (IABP): IABP-SHOCK II showed no mortality benefit in MI-related cardiogenic shock. Its role in post-arrest cardiogenic shock is limited.
- Impella CP or Impella 5.0/5.5 (Abiomed, FDA-cleared PMA): Provides 2.5 to 5.5 L/min of hemodynamic support. Limited RCT data in the specific post-arrest cardiogenic shock population; observational data from registries suggest benefit in selected patients 3 / Early .
- VA-ECMO: Extracorporeal membrane oxygenation provides full cardiorespiratory support. Used in refractory arrest (E-CPR, extracorporeal CPR) as a bridge to recovery or decision. The ARREST trial (Yannopoulos et al., Lancet 2020, 10.1016/S0140-6736(20)32338-2) showed survival benefit for E-CPR in refractory VFib at a dedicated center. Access to VA-ECMO is limited to high-volume centers.
The decision to escalate to MCS requires simultaneous neurological assessment: providing mechanical support to a patient with irreversible anoxic brain injury extends dying, not surviving. This is the intersection of hemodynamics and ethics that defines post-arrest care at its most complex.
The Post-Arrest Patient in Rural Illinois
For patients resuscitated in rural settings and transported to regional hospitals without dedicated post-arrest programs, outcomes are measurably worse. Transfer to a tertiary center with a formal post-arrest care protocol, cardiac catheterization capability, continuous EEG monitoring, and neurology consultation is associated with better outcomes 4 / Promising .
Carle Foundation Hospital in Urbana runs a post-arrest ICU protocol meeting ILCOR guidelines. For patients in extreme rural settings, ground or air transport to Carle Foundation Hospital or to OSF Saint Francis Medical Center in Peoria should be considered for all patients achieving ROSC outside these centers.
The SDE Synthesis
ROSC is the rescue that makes every subsequent decision possible. Post-cardiac arrest syndrome is the reason that rescue alone is insufficient.
The Stop Dying Early framework engages post-arrest care at the boundaries it can influence: identifying patients at risk before the arrest, ensuring they are connected to appropriate follow-up after the arrest, and providing the family-level education that gives post-arrest survivors the support structure that the healthcare system often withdraws too quickly.
The question families ask at the ICU bedside is “will he wake up?” The question they need to be equipped to ask six months later is “what does his recovery require from us?” That transition, from crisis to ongoing rehabilitation, is where most post-arrest patients and families are underserved.
Post-cardiac arrest care is one of the most evidence-active areas of resuscitation medicine. Multiple large trials are ongoing, including trials of neuroprotection strategies, oxygen targets, and post-arrest rehabilitation. The ILCOR guidelines are reviewed and updated annually. The management described in this article reflects the best available evidence as of mid-2026.
The Role of Cardiac Rehabilitation After Cardiac Arrest
Cardiac rehabilitation has a well-established evidence base for post-MI and heart failure patients, but its application to cardiac arrest survivors is underrecognized. The post-arrest patient faces a unique rehabilitation challenge: neurological, cardiovascular, and psychological sequelae that interact and compound.
Exercise-based cardiac rehabilitation: Formal cardiac rehabilitation programs (Phase I, II, and III) improve exercise capacity, reduce rehospitalization, and reduce cardiovascular mortality in cardiac patients generally 5 / Solid . For post-arrest survivors, the evidence is specifically less developed, but observational data consistently show that survivors who engage in structured rehabilitation have better six-month functional outcomes and lower anxiety scores 4 / Promising .
Cognitive rehabilitation: Neuropsychological deficits after cardiac arrest respond to structured cognitive rehabilitation programs. These programs, which combine cognitive exercises, compensatory strategy training, and behavioral counseling, are available through specialized brain injury rehabilitation programs (not yet standard in cardiac rehabilitation centers) 4 / Promising .
Psychological support: PTSD symptoms in post-arrest survivors occur at rates of 15 to 40 percent 5 / Solid . These are not resolved by standard cardiac follow-up. Referral to psychologists familiar with cardiac arrest sequelae, or to the growing number of cardiac arrest survivor support programs (SERCA: Sudden Cardiac Arrest Survivors Foundation; SCAI: Survivors of Cardiac Arrest International) is an underutilized resource.
Return to driving: The regulatory landscape for driving after cardiac arrest varies by state. Most states require a period of arrhythmia-free observation (typically three to six months) before resuming driving. For ICD recipients, this is coordinated between the cardiologist and the relevant state motor vehicle authority. Patients should not resume driving until cleared explicitly; uncoordinated return to driving after cardiac arrest is a public safety issue that is too frequently not addressed at discharge.
The Family’s Role in Post-Arrest Recovery
The cardiac arrest survivor does not recover alone. The family member who witnessed the arrest, performed CPR, or waited in the ICU waiting room for four days carries their own clinical burden, and that burden directly affects the patient’s recovery.
Family caregiver strain: Longitudinal studies of cardiac arrest survivors document high rates of caregiver burnout in the six to twelve months post-discharge 4 / Promising . Caregivers who do not receive their own psychological support have higher rates of depression and are more likely to limit the patient’s rehabilitation activities out of fear of recurrence.
The ICD anxiety problem in households: ICD recipients and their family members both experience anxiety about device shocks. Studies document that family members of ICD patients reduce physical contact with the patient (fear of receiving a shock themselves, which is physiologically benign through a hug but psychologically significant) and restrict the patient’s activities beyond what is clinically indicated 4 / Promising . Electrophysiology nurses and cardiac device clinics that include family education about ICD physiology and shock response reduce these behavioral restrictions.
Communication across the care transition: The discharge conversation for a cardiac arrest survivor should include both the patient and their primary caregiver, covering: ICD function and what to do if it fires, warning symptoms that warrant immediate 911 activation, the timeline for follow-up appointments, and how to access the SDE Cohort program or equivalent post-arrest support structure.
Long-Term Prognosis After Cardiac Arrest
The survival statistics cited in this article describe outcomes to hospital discharge. The longer-term prognosis is less well-characterized but is clinically important for patients and families making decisions about returning to work, planning further pregnancies, modifying lifestyle, or simply understanding their outlook.
Five-year survival after OHCA in patients who are discharged with good neurological function (CPC 1-2) ranges from 65 to 80 percent in contemporary registry data, which is substantially better than the 30 to 50 percent five-year survival historically reported 4 / Promising . The improvement reflects better post-arrest care, more consistent ICD implantation, and better optimization of underlying cardiovascular disease.
Recurrent cardiac arrest in ICD recipients is prevented by appropriate device therapy in 10 to 15 percent of patients per year (the rate of appropriate ICD shocks), confirming that the underlying arrhythmia substrate persists but is being managed 5 / Solid . A meaningful fraction of ICD patients never receive a shock. This is not a reason to remove the device; it is evidence that the arrhythmia has not recurred, which is the desired outcome.
Quality of life after cardiac arrest is variable but is often better than physicians and families expect during the crisis. Long-term follow-up studies document that the majority of CPC 1-2 survivors rate their quality of life as good or excellent at one and five years, though they remain at raised risk for depression and anxiety 4 / Promising 00753-7). These data are relevant to the goals-of-care conversation: the statistical question is not just “will he survive?” but “if he survives, what will his life look like?” The answer, for the majority of patients with good initial recovery, is: a good life, with monitoring, with an ICD, and with ongoing clinical partnership.
The Neurological Recovery Trajectory — What Families Need to Understand
The neurological outcome after cardiac arrest is the central concern for survivors and their families. It is also the area of greatest uncertainty and the source of the most consequential clinical conversations in post-arrest care. Families who wait at the ICU bedside during the comatose phase of post-arrest care are trying to answer a question that the clinical team cannot always answer clearly: “Will my family member be the same person they were before?”
The honest answer, during the first 72 hours, is: “We do not know with certainty. Here is what the current clinical data tells us, and here is our process for gathering more information.”
The Neuroprognostication Multimodal Approach
The 2021 European Resuscitation Council/European Society of Intensive Care Medicine (ERC-ESICM) guidelines for post-arrest neuroprognostication recommend a multimodal approach using no fewer than two independent tests before concluding that a poor neurological outcome is certain 5 / Solid .
The test battery includes:
Clinical examination at 72 hours: Bilateral absence of pupillary reflexes carries a false positive rate (incorrectly predicting poor outcome in a patient who actually recovers) of approximately 1 percent for poor outcome when both pupils are absent 5 / Solid . Absence of corneal reflexes is less specific. Presence of a myoclonic status epilepticus within 72 hours of arrest, particularly of the continuous, generalized, tonic variety, carries a high false positive rate for poor outcome in the absence of other supporting data and should not be used in isolation.
SSEP (somatosensory evoked potentials) at 24-48 hours: Bilateral absence of cortical N20 response is one of the most reliable prognostic markers available. In a patient who remains comatose after target temperature management, bilateral absent N20 carries a false positive rate for poor neurological outcome approaching 0 percent in multiple large series 5 / Solid . This test is available at Northwestern Medicine Chicago, Carle Foundation Hospital Urbana (with neurophysiology expertise), and most academic and large community medical centers in Illinois.
EEG (electroencephalogram) at 24-72 hours: Burst suppression and malignant patterns predict poor outcomes, but the interpretation is complex and requires neurophysiology expertise. Continuous EEG monitoring for 24 to 48 hours allows detection of subclinical seizures that may be contributing to secondary brain injury and may be treatable 4 / Promising .
Neuron-specific enolase (NSE) at 48-72 hours: NSE is a neuronal injury biomarker that is released into the bloodstream with neuronal death. Levels above 60 mcg/L at 48 or 72 hours predict poor outcome with low false positive rates when interpreted in the full clinical context 5 / Solid . Hemolysis artificially raises NSE (erythrocytes contain NSE), and hemolysis must be excluded before interpreting raised values.
Brain CT and MRI: CT on admission excludes intracranial hemorrhage as the cause of arrest. MRI at 3 to 5 days after arrest, when diffusion-weighted imaging abnormalities are most prominent, provides direct visualization of cortical injury patterns that correlate with neurological outcome 5 / Solid .
The protocol at most academic medical centers integrates all of these modalities before a final prognostic statement is made. The family is told at each time point what is known, what remains uncertain, and what additional information will be available at the next assessment window. Premature withdrawal of life support before the multimodal assessment is complete has been associated with worse outcomes in some studies , the self-fulfilling prophecy concern, where early withdrawal preempts potential recovery 4 / Promising .
The CIBS (Cognitive Impairment in Cardiac Arrest Survivors) Problem
Brain injury after cardiac arrest is not always catastrophic or obvious. The majority of survivors who achieve a cerebral performance category (CPC) score of 1 or 2 ( functionally independent ) still demonstrate cognitive impairments on formal neuropsychological testing that would not be apparent on a bedside neurological examination 5 / Solid .
The domains most commonly affected are memory (particularly episodic memory for new information), executive function (planning, sequencing, problem-solving), and information processing speed. A survivor who returns to work and resumes their daily activities may still be functioning at a significantly reduced cognitive level compared to their pre-arrest baseline , a reduction that is invisible on standard clinical follow-up.
The implications are practical: the patient who was a surgeon, a lawyer, or a physician may not have the cognitive processing speed to safely return to their prior professional role without cognitive rehabilitation and formal neuropsychological assessment. The patient who manages their own complex medication regimen, finances, and household may need support infrastructure that their family did not anticipate.
Formal neuropsychological evaluation at 3 and 12 months post-arrest should be standard for all CPC 1-2 survivors 4 / Promising . It rarely is in current practice. The neuropsychological evaluation that identifies a processing speed deficit at 3 months allows targeted cognitive rehabilitation intervention at the most neuroplastic period post-injury.
Coronary Angiography After ROSC — Timing, Selection, and the COACT Evidence
Among survivors of OHCA, coronary artery disease is the most common underlying cause of the arrest. Identifying and treating the causative coronary lesion is a central goal of post-ROSC management. But the clinical question ( whether immediate coronary angiography after ROSC improves outcomes in all comatose survivors ) has been answered more definitively than most cardiologists expected by the COACT trial.
The COACT Trial and Its Implications
The COACT trial (Coronary Angiography After Cardiac Arrest) enrolled 552 patients resuscitated from OHCA without ST-elevation on the post-ROSC ECG and randomized them to immediate coronary angiography (within 2 hours of ROSC) versus delayed coronary angiography (after neurological recovery, if indicated). At 90 days, survival was 64.5 percent in the immediate angiography group versus 67.2 percent in the delayed group (absolute difference: -2.8 percent; 95% CI -11.2 to 5.6 percent) 5 / Solid .
Immediate angiography did not improve 90-day survival, neurological outcomes, or any secondary endpoint compared to delayed angiography in patients without STEMI.
This finding fundamentally changed post-arrest management guidelines for non-STEMI survivors. The 2021 ACC/AHA/SCAI guidelines no longer recommend immediate angiography for all comatose OHCA survivors without STEMI. The decision is individualized based on clinical features suggesting active ischemia: dynamic ECG changes, hemodynamic instability consistent with cardiogenic shock from a culprit lesion, or clinical features strongly suggesting ACS (chest pain before collapse, enzyme elevation pattern consistent with plaque rupture).
The unchanged recommendation: OHCA survivors with ST-elevation on post-ROSC ECG proceed to the cardiac catheterization laboratory emergently regardless of neurological status 5 / Solid . The benefit of primary PCI in STEMI extends to resuscitated arrest patients.
Right Ventricular Failure Post-Arrest and the Hemodynamic Profile
A complication that cardiologists and intensivists must recognize in post-ROSC management is the post-resuscitation cardiac dysfunction that affects both the LV and RV. Post-arrest myocardial stunning ( global LV and RV dysfunction that occurs in the first 24 to 48 hours post-ROSC ) is distinct from the pre-existing cardiomyopathy that may have contributed to the arrest.
Post-arrest RV dysfunction, from pulmonary hypertension secondary to hypoxia and acidosis during the arrest, may be more hemodynamically dominant than LV dysfunction in some patients. The patient with post-ROSC shock who has a preserved or even hyperdynamic LV on echo but a dilated, hypokinetic RV with raised pulmonary pressures has a different hemodynamic profile than the patient with LV-predominant post-arrest stunning. Management targeting RV afterload reduction (inhaled pulmonary vasodilators, avoidance of hypoxia and hypercarbia, careful volume management) differs from the approach to LV-predominant shock.
Point-of-care echocardiography in the ICU ( or formal TTE within the first 24 hours ) should assess biventricular function as a standard component of post-ROSC hemodynamic evaluation 5 / Solid .
Seizure Management in the Post-Arrest Period
Post-anoxic seizures occur in approximately 20 to 30 percent of comatose post-arrest patients 5 / Solid . Clinical seizures (convulsive movements) are identifiable at the bedside. Non-convulsive status epilepticus is not, and requires continuous EEG for detection. Both forms of post-anoxic seizure contribute to secondary neuronal injury through increased metabolic demand and neurotoxic glutamate release.
The appropriate treatment strategy for post-anoxic seizure is debated. Aggressive suppression with phenobarbital, propofol infusion, or benzodiazepine regimens is effective at stopping electrical seizure activity on EEG. Whether suppressing the electrical activity improves neurological outcomes, or whether the seizures in some cases represent a marker of severe underlying injury that cannot be reversed regardless of treatment, is not established by RCT evidence 2 / Theoretical .
Current practice at most post-arrest programs is to suppress clinical and confirmed non-convulsive seizures with standard antiseizure medications and to use continuous EEG monitoring to document response to therapy, while not attempting burst suppression on EEG in the absence of refractory seizure activity.
ICU Communication Standards for Post-Arrest Families
The post-arrest ICU is one of the most communication-intensive clinical environments in medicine. A comatose patient cannot speak for themselves. The family is often in acute crisis, having watched (or been told about) a collapse that was life-threatening. The clinical team is managing a complex, rapidly evolving physiological situation while simultaneously trying to provide informational updates to a family who is consuming every word for evidence about the likelihood of survival and recovery.
The failures in this communication environment are well-documented: families who received inaccurate early prognosis, who feel information was withheld from them, who experienced inconsistency between team members’ statements, or who were present for resuscitation decisions they did not feel equipped to participate in 5 / Solid . These failures produce prolonged family grief reactions, distrust of the healthcare system, and in some cases, litigation.
The Family Meeting Protocol
High-performance post-arrest ICU programs conduct structured family meetings at defined intervals: within 24 hours of admission, at 72 hours (when neuroprognostication data begins to mature), and then as needed. Each meeting follows a consistent structure: what happened, what has been done, what the current status is, what data will be available and when, and what decisions may be required and by whom.
The 24-hour meeting is not a prognostic meeting. It is an orientation meeting: the ICU environment is explained, the monitoring and support equipment is described, the treatment plan for the next 24-48 hours is outlined, and the family is given a single point of contact for questions. Premature prognostic statements at 24 hours, before neuroprognostication data is available, create anchoring effects that are difficult to reverse even when later data suggests a different trajectory.
The 72-hour meeting is the prognostic meeting. By this point, the clinical team has neurological examination data, NSE levels, SSEPs if obtained, and potentially MRI and EEG data. The meeting presents this data clearly, explains what each test contributes to the probability estimate, and where appropriate, begins the conversation about goals of care.
The language of probability is clinically honest and practically useful: “Based on the tests we have done, we estimate that the probability of a functionally independent recovery is approximately X percent. The tests that would give us a higher or lower confidence estimate are: [list]. We will have those results in [timeframe]. We want to make decisions with you based on the best available evidence, not before it.”
This is not false optimism. It is not premature closure. It is honest medical communication about the limits of knowledge at a defined point in time.
Depression, PTSD, and the Psychological Aftermath of Cardiac Arrest
Cardiac arrest is a trauma event: sudden loss of consciousness, resuscitation, ICU admission, and the confrontation with near-death. The psychological consequences are substantial and underrecognized. Post-cardiac arrest PTSD symptoms occur in approximately 22 to 38 percent of survivors 5 / Solid . Depression affects approximately 14 to 45 percent of post-arrest survivors at 1 year 5 / Solid . Anxiety disorders are common. Family members of arrest survivors also experience high rates of PTSD and complicated grief, even when the survivor makes a full physical recovery.
The ICU discharge does not end the psychological care requirement. At Carle Foundation Hospital in Urbana and at Northwestern Medicine in Chicago, post-arrest survivor clinics incorporate psychology or social work consultations as a standard component of the 30-day and 3-month follow-up visits. The SDE Cohort program for post-arrest patients includes a mental health resource referral and a structured screening with the PHQ-9 and PTSD screening tools at the 3-month visit.
The bystander rescuer is also a patient. Studies of bystanders who performed CPR on a family member or stranger ( particularly cases where the cardiac arrest victim did not survive ) show significant rates of PTSD and depression in the rescuer 3 / Early . This population is largely invisible to the healthcare system, which follows the patient but not the rescuer. Recognizing the rescuer as a person who may need psychological support is part of the full post-arrest community response.
The Rehabilitation Gap in Post-Arrest Care
Cardiac rehabilitation programs for post-MI patients are among the most evidence-based interventions in cardiovascular medicine, with meta-analyses showing 20 to 26 percent reductions in cardiovascular mortality and 18 to 30 percent reductions in all-cause mortality among participants 5 / Solid . Yet cardiac rehabilitation referral rates in the U.S. remain below 40 percent for eligible patients, and post-arrest survivors are among the lowest-referred subgroups 5 / Solid .
The reasons for the post-arrest rehabilitation gap include: the complexity of the acute hospitalization, which makes discharge planning for rehabilitation a lower priority; the uncertainty about functional recovery that makes rehabilitation referral feel premature to some clinicians; the absence of specific post-arrest rehabilitation protocols tailored to the cognitive and psychological sequelae of anoxic brain injury; and the lack of payer coverage for cognitive rehabilitation under many U.S. insurance plans.
Post-arrest cardiac rehabilitation programs that include both physical conditioning and cognitive rehabilitation have been piloted at several academic centers. A program at Aarhus University in Denmark showed that post-arrest survivors randomized to a 12-week rehabilitation program incorporating exercise, nutrition counseling, and cognitive rehabilitation had improved quality of life, exercise capacity, and cognitive performance at 6 months compared to standard follow-up 4 / Promising .
The rehabilitative model for post-arrest care is not different in principle from the rehabilitative model for stroke, major trauma, or other acute neurological injuries. It requires an organized program, defined goals, structured progress measurement, and longitudinal follow-up. What it also requires is the clinical recognition that cardiac arrest is a neurological injury as much as it is a cardiac event, and that the downstream care should reflect both dimensions.
Post-Arrest Transition of Care — Closing the Follow-Up Gap
The cardiac arrest survivor who is discharged from the ICU to a step-down unit, then to the hospital floor, then to a skilled nursing facility or home, experiences a series of care transitions during which clinical information is often lost, medication reconciliation fails, and follow-up appointments are not scheduled with appropriate urgency.
A structured post-arrest care bundle should include, at discharge from the acute hospital:
- A cardiology follow-up appointment within 7 days
- An ICD device check if a device was implanted
- A medication reconciliation review with particular attention to proarrhythmic medications, QT-prolonging agents, and interactions between new post-arrest medications and pre-arrest regimen
- A clear communication to the patient (and family, for cognitive recovery patients) about what happened, what was treated, what the device does, and what symptoms require emergent contact
- A neuropsychological screening referral if any cognitive concerns were noted during hospitalization
- A cardiac rehabilitation referral with a specific program identified
The 7-day follow-up appointment is not bureaucratic. It is the clinical safety net for the patient who was started on an ACE inhibitor and a beta-blocker in the ICU, was discharged on a Friday, missed a dose, became bradycardic on the weekend, and presented to the emergency department at the facility across town from the cardiologist who placed the ICD. The 7-day appointment catches this before the emergency department does.
The SDE Cohort program provides this structure for enrolled patients. The post-arrest SDE care plan generates the 7-day cardiology appointment, the neuropsychological referral, the cardiac rehabilitation enrollment, and the medication review as a single coordinated package at discharge. The cardiologist who manages the patient’s ICD and the cardiologist who manages the cardiac rehabilitation and secondary prevention are the same person, operating with a complete longitudinal record. This is the level of coordination that post-arrest care requires and that episodic, fragmented care delivery cannot consistently provide.
For the 46-year-old in the opening scenario who survived his arrest and was discharged with a functioning ICD and a prescription for metoprolol: his outcome was shaped by everything that happened in the 72 hours after ROSC, but it will be maintained or undermined by everything that happens in the following 5 years. The clinical decision architecture does not end when he walks out of the hospital. It begins a new phase: the long-term survival phase, in which secondary prevention, device management, cognitive monitoring, psychological support, and family preparation are the active clinical interventions.
Start with the gap between how you appear and what your body is doing.
Take the Signal CheckDid this land?
The conversation
Join the men working through this in the open.